Rize Oncology Inc. (GTTX)
Market Closed
7 Jan, 16:43
CNSX CNSX Primary CA$
0. 12
0
0%
CA$
968.62K Market Cap
- P/E Ratio
- Div Yield
0 Volume
0 Eps
CA$ 0.12
Previous Close Want to track GTTX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Summary
GTTX closed Tuesday higher at CA$0.12, an increase of 0% from Monday's close, completing a monthly increase of 0% or CA$0.12. Over the past 12 months, GTTX stock gained 0%.
GTTX is not paying dividends to its shareholders.
The stock of the company had never split.
The company's stock is traded on one exchange.
GTTX Chart
Rize Oncology Inc. (GTTX) FAQ
What is the stock price today?
The current price is CA$0.12.
On which exchange is it traded?
Rize Oncology Inc. is listed on CNSX.
What is its stock symbol?
The ticker symbol is GTTX.
Does it pay dividends? What is the current yield?
It does not pay dividends to its shareholders.
What is its market cap?
As of today, the market cap is 968.62K.
Has Rize Oncology Inc. ever had a stock split?
No, there has never been a stock split.
Rize Oncology Inc. Profile
| - Industry | - Sector | Mr. Roland Boivin CEO | CNSX Exchange | CA37187D1087 ISIN |
| Canada Country | - Employees | - Last Dividend | - Last Split | - IPO Date |
GeneTether Therapeutics Inc., a biopharmaceutical company, focuses on the development of precision gene editing therapies based on its GeneTether platform for human therapeutics applications. It is developing gene therapies for the treatment of patients with rare and monogenic kidney and skin diseases. The company was founded in 2018 and is based in Kelowna, Canada.
Contact Information
Address: 301 – 1665 Ellis Street
Phone: 514-796-2640
Website: https://genetether.com
